4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-24-000276
Options or other derivatives
- PRESIDENT AND CEO acquired 177,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Russo Rene PRESIDENT AND CEO | 2024-01-01 | Grant or award · Restricted Stock Units | +177,000 | 177,000 | D | ||
Loading xslF345X05/form4-01032024_040101.xml…